IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 23 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,336 | – | 1,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,028,253 | $1,882 | 0.09% |
| Gradient Capital Advisors, LLC | 26,808 | $49,059 | 0.02% |
| WEST PACES ADVISORS INC. | 1,665 | $3,047 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 15,927 | $29,147 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,382 | $4,359 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $31,995 | 0.00% |
| CITIGROUP INC | 7 | $13 | 0.00% |
| MORGAN STANLEY | 533 | $975 | 0.00% |
| Rathbones Group PLC | 14,000 | $25,620 | 0.00% |